Biochemical pharmacologyPaclitaxelHumansFemaleTacrolimus Binding ProteinsDrug Resistance
FKBP38 expression level dictates paclitaxel resistance via interacting with Bcl-2 in endometrial cancer.
Yunjing Yan, Yimei Lai, Minyi Tang, Shuai Wang, Gengmiao Xiao, Yunping Mu, Xiaoli Wu, Allan Z Zhao, Fanghong Li
Published: 202610.1016/j.bcp.2025.117437
Abstract
Endometrial cancer (EC) is a gynecological malignancy that faces the serious challenge of chemotherapy resistance. Therefore, there is an urgent clinical need to investigate this issue. In this study, we focused on the potential role of FKBP38, a mem…
Preview only. Read the full abstract at the source